Zobrazeno 1 - 10
of 76
pro vyhledávání: '"C. Blein"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Value in Health. 25:S224
Publikováno v:
Value in Health. 25:S191
Autor:
R Supiot, A Millier, K Benyounes, V Machuron, K Le Lay, M Sivignon, C Leboucher, C Blein, F Raffi
Publikováno v:
Value in Health. 25:S203
Autor:
C. Leboucher, C. Blein, A. Le Maout, V. Machuron, K. Benyounes, K. Le Lay, A. Millier, Pr Raffi
Publikováno v:
Revue d'Épidémiologie et de Santé Publique. 70:S274
RWD65 Overview of Recent Applications of Artificial Intelligence for Real World Evidence Development
Publikováno v:
Value in Health. 25:S588
Publikováno v:
Value in Health. 25:S614
Diversité des prises en charge des patients atteints de sclérose en plaques entre régions françaises
Publikováno v:
Revue d'Épidémiologie et de Santé Publique. 66:385-394
Background The aim of this study is to analyze and to compare data from 2015, focusing on hospital care for patients with multiple sclerosis from three French regions with different characteristics in terms of prevalence, size and number of multiple
Autor:
Alexandre Vainchtock, C. Tournier, Arnaud Scherpereel, Jean Baptiste Assié, Pascal Andujar, Jean Claude Pairon, C. Blein, Isabelle Monnet, Christos Chouaid
Publikováno v:
Cancer Medicine
Cancer Medicine, 2018, 7 (4), pp.1102-1109. ⟨10.1002/cam4.1378⟩
Cancer Medicine, 2018, 7 (4), pp.1102-1109. ⟨10.1002/cam4.1378⟩
International audience; This study was undertaken to determine the healthcare burden of malignant pleural mesothelioma (MPM) in France and to analyze its associations with socioeconomic deprivation, population density, and management outcomes. A nati
Autor:
Pierre-Jean Souquet, Alexandre Vainchtock, Isabelle Durand-Zaleski, J Fernandes, Pierre Chauvin, Anne-Françoise Gaudin, Virginie Westeel, C. Tournier, Arnaud Scherpereel, C. Blein, Didier Debieuvre, Christos Chouaid, François-Emery Cotté
Publikováno v:
BMC Cancer
BMC Cancer, BioMed Central, 2018, 18, pp.1013. ⟨10.1186/s12885-018-4958-5⟩
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
BMC Cancer, BioMed Central, 2018, 18, pp.1013. ⟨10.1186/s12885-018-4958-5⟩
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
International audience; Background: Territorial differences in the access to innovative anticancer drugs have been reported from many countries. The objectives of this study were to evaluate access to innovative treatments for metastatic lung cancer